4th ADC Toxicity Summit

The 4th ADC Toxicity Summit takes place from 25 August 2026 in Boston, organised by Hanson Wade. As antibody-drug conjugate pipelines grow rapidly, toxicity remains one of the biggest barriers to clinical success, patient safety and regulatory approval; recent safety setbacks across major ADC programmes have intensified industry focus on toxicity prediction, translational safety assessment and dose optimization. The summit is the only dedicated industry forum focused exclusively on preventing, predicting and mitigating ADC toxicities across preclinical and clinical development, bringing together toxicologists, translational scientists, pharmacologists, clinicians and safety leaders from pharma, biotech and academia.